| Quality Health Care Llc | |
|
12 Havemeyer Pl Greenwich CT 06830-2533 | |
| (860) 554-9021 | |
| Not Available |
| Full Name | Quality Health Care Llc |
|---|---|
| Speciality | Internal Medicine |
| Location | 12 Havemeyer Pl, Greenwich, Connecticut |
| Authorized Official Name and Position | Karla Orea (OWWNER) |
| Authorized Official Contact | 8605549021 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Quality Health Care Llc 12 Havemeyer Pl Greenwich CT 06830-2533 Ph: (860) 554-9021 | Quality Health Care Llc 12 Havemeyer Pl Greenwich CT 06830-2533 Ph: (860) 554-9021 |
| NPI Number | 1023716032 |
|---|---|
| Provider Enumeration Date | 02/20/2023 |
| Last Update Date | 02/20/2023 |
| Medicare PECOS PAC ID | 8820453699 |
|---|---|
| Medicare Enrollment ID | O20230501000241 |
News Archive
OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC marketplace, today announced that Impax Pharmaceuticals, the brand division of Impax Laboratories, Inc., Hayward, CA, has selected the TrialMaster EDC solution for conducting a Phase III study in patients with Parkinson's Disease. "While managing a global multi site clinical trial there can be significant challenges in getting trial data when you want it and in the format that you need it," said Suneel Gupta, PhD, Chief Scientific Officer for Impax. "The TrialMaster EDC solution provides us with an intuitive and easy to use export tool that simplifies the process. After considering multiple different EDC solutions, we selected OmniComm Systems based on its customer driven approach and reputation for delivering unparalleled service and support. Additionally, its support of industry standards has enabled us to meet our very tight corporate timelines for this important study."
Thousands of people with disabilities, their families, caregivers, seniors, wounded veterans and healthcare professionals are expected to attend Abilities Expo on February 5-7, 2016 at the Los Angeles Convention Center, West Hall A. Admission is free and the new show hours will get attendees home in time to watch the Super Bowl: Friday 11 am to 5 pm, Saturday 10 am to 6 pm and Sunday 10 am to 2 pm.
Fruit flies are notoriously short-lived but scientists interested in the biology of aging in all animals have begun to understand why some fruit flies live longer than others. They have documented a direct association between insulin and life span, for example, and have observed a tradeoff between prolific reproduction and longevity. A new study, which may have broad implications across species, ties those findings more closely together by tracing an insulin signaling cascade through to protein quality control in muscle tissue and shortened life span.
Iowa State University researchers have identified a protein essential for building memories that appears to predict the progression of memory loss and brain atrophy in Alzheimer's patients.
Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for ELIQUIS® (apixaban), an investigational compound for the prevention of stroke and systemic embolism in patients with atrial fibrillation.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023716032 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Lizeth Diaz Ledesma |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1700085784 PECOS PAC ID: 0042385684 Enrollment ID: I20230221001371 |
News Archive
OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC marketplace, today announced that Impax Pharmaceuticals, the brand division of Impax Laboratories, Inc., Hayward, CA, has selected the TrialMaster EDC solution for conducting a Phase III study in patients with Parkinson's Disease. "While managing a global multi site clinical trial there can be significant challenges in getting trial data when you want it and in the format that you need it," said Suneel Gupta, PhD, Chief Scientific Officer for Impax. "The TrialMaster EDC solution provides us with an intuitive and easy to use export tool that simplifies the process. After considering multiple different EDC solutions, we selected OmniComm Systems based on its customer driven approach and reputation for delivering unparalleled service and support. Additionally, its support of industry standards has enabled us to meet our very tight corporate timelines for this important study."
Thousands of people with disabilities, their families, caregivers, seniors, wounded veterans and healthcare professionals are expected to attend Abilities Expo on February 5-7, 2016 at the Los Angeles Convention Center, West Hall A. Admission is free and the new show hours will get attendees home in time to watch the Super Bowl: Friday 11 am to 5 pm, Saturday 10 am to 6 pm and Sunday 10 am to 2 pm.
Fruit flies are notoriously short-lived but scientists interested in the biology of aging in all animals have begun to understand why some fruit flies live longer than others. They have documented a direct association between insulin and life span, for example, and have observed a tradeoff between prolific reproduction and longevity. A new study, which may have broad implications across species, ties those findings more closely together by tracing an insulin signaling cascade through to protein quality control in muscle tissue and shortened life span.
Iowa State University researchers have identified a protein essential for building memories that appears to predict the progression of memory loss and brain atrophy in Alzheimer's patients.
Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for ELIQUIS® (apixaban), an investigational compound for the prevention of stroke and systemic embolism in patients with atrial fibrillation.
› Verified 9 days ago
News Archive
OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC marketplace, today announced that Impax Pharmaceuticals, the brand division of Impax Laboratories, Inc., Hayward, CA, has selected the TrialMaster EDC solution for conducting a Phase III study in patients with Parkinson's Disease. "While managing a global multi site clinical trial there can be significant challenges in getting trial data when you want it and in the format that you need it," said Suneel Gupta, PhD, Chief Scientific Officer for Impax. "The TrialMaster EDC solution provides us with an intuitive and easy to use export tool that simplifies the process. After considering multiple different EDC solutions, we selected OmniComm Systems based on its customer driven approach and reputation for delivering unparalleled service and support. Additionally, its support of industry standards has enabled us to meet our very tight corporate timelines for this important study."
Thousands of people with disabilities, their families, caregivers, seniors, wounded veterans and healthcare professionals are expected to attend Abilities Expo on February 5-7, 2016 at the Los Angeles Convention Center, West Hall A. Admission is free and the new show hours will get attendees home in time to watch the Super Bowl: Friday 11 am to 5 pm, Saturday 10 am to 6 pm and Sunday 10 am to 2 pm.
Fruit flies are notoriously short-lived but scientists interested in the biology of aging in all animals have begun to understand why some fruit flies live longer than others. They have documented a direct association between insulin and life span, for example, and have observed a tradeoff between prolific reproduction and longevity. A new study, which may have broad implications across species, ties those findings more closely together by tracing an insulin signaling cascade through to protein quality control in muscle tissue and shortened life span.
Iowa State University researchers have identified a protein essential for building memories that appears to predict the progression of memory loss and brain atrophy in Alzheimer's patients.
Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for ELIQUIS® (apixaban), an investigational compound for the prevention of stroke and systemic embolism in patients with atrial fibrillation.
› Verified 9 days ago
Center For Gastrointestinal Medicine Of Fairfield & Westchester, P.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 500 W Putnam Ave, Suite 100, Greenwich, CT 06830 Phone: 203-863-2900 Fax: 203-863-2901 | |
Signature Concierge Physicians, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 32 Field Point Rd, Greenwich, CT 06830 Phone: 203-962-1009 | |
Christopher M Edelmann,m.d.,p.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 42 Sherwood Pl, Greenwich, CT 06830 Phone: 203-869-0502 Fax: 203-869-1852 | |
Family Centers Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1 Wilbur Peck Ct Lowr Level, Greenwich, CT 06830 Phone: 203-829-2822 Fax: 203-829-2940 | |
Halsamd Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 115 E Putnam Ave, Greenwich, CT 06830 Phone: 203-517-4600 Fax: 888-397-2148 | |
Palliative Care Pans Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4 Charter Oak Ln, Greenwich, CT 06830 Phone: 203-921-7836 Fax: 203-433-5823 |